Last reviewed · How we verify

NCT05850442

The Relationship Between Fibromyalgia Syndrome Parameters With Disease-Pain Severity and the Quality Of Life

Completed Last updated 2 April 2025
What this trial tests

trial testing Questionary in Fibromyalgia Syndrome in 130 participants. Completed in 1 December 2024.

Timeline
1 April 2023
Primary endpoint
1 December 2024
1 December 2024

Quick facts

Lead sponsorUmraniye Education and Research Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment130
Start date1 April 2023
Primary completion1 December 2024
Estimated completion1 December 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Umraniye Education and Research Hospital

Who can join

Adults 18 to 65, any sex, with Fibromyalgia Syndrome or Anxiety Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, the investigators aim to evaluate the relationship between disease severity, quality of life, anxiety and pain level in patients diagnosed with Fibromyalgia Syndrome (FMS) with the parameters according to the American College of Rheumatology (ACR) 2016 diagnostic criteria. According to the 2016 ACR diagnostic criteria, there are 2 separate scales: Widespread Pain Index (WPI) and Symptom Severity (SS) . The relationship between these 2 parameters and the Fibromyalgia Impact Questionnaire, the World Health Organization Short Quality of Life Questionnaire, and the McGill Melzack Pain Questionnaire and Beck Anxiety Questionnaire will be examined.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Questionary

Trials testing the same drug.

Other recruiting trials for Fibromyalgia Syndrome

Currently open trials in the same condition.

Other Umraniye Education and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05850442.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing